Medications

Romosozumab substantially builds bone density in hip and spine

New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine ...

Arthritis & Rheumatism

Exercise in early 20s may lower risk of osteoporosis

Physical exercise in the early twenties improves bone development and may reduce the risk of fractures later in life, reveals a study of more than 800 Swedish men carried out at the Sahlgrenska Academy at the University of ...

page 3 from 15